Skip to content

Hormone receptor status of Adrenocortical Carcinoma

Hormone receptor status of Adrenocortical Carcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/03/006733
Enrollment
50
Registered
2016-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Adrenocortical carcinoma

Interventions

None listed

Sponsors

Dr Ganesh Bakshi
Lead Sponsor
Dr Santosh Menon Dr Gagan Prakash Dr Anup Tamhankar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: patients diagnosed as ACC previously at our institute and with sufficient tissue material would be included.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinicopathological, Demographic and immunohistochemical scoring would be correlated with stage, recurrences and overall survival in available casesTimepoint: Clinicopathological, Demographic and immunohistochemical scoring would be correlated with stage, recurrences and overall survival in available cases

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Ganesh Bakshi

Tata Memorial Hospital

gkbakshi1973@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026